These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21084749)

  • 1. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
    McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
    J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
    Zhang Y; Ma CJ; Wang JM; Ji XJ; Wu XY; Jia ZS; Moorman JP; Yao ZQ
    PLoS One; 2011; 6(5):e19664. PubMed ID: 21637332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
    Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
    J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
    Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
    Kroy DC; Ciuffreda D; Cooperrider JH; Tomlinson M; Hauck GD; Aneja J; Berger C; Wolski D; Carrington M; Wherry EJ; Chung RT; Tanabe KK; Elias N; Freeman GJ; de Kruyff RH; Misdraji J; Kim AY; Lauer GM
    Gastroenterology; 2014 Feb; 146(2):550-61. PubMed ID: 24148617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
    Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
    J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation.
    Larrubia JR; Lokhande MU; García-Garzón S; Miquel J; González-Praetorius A; Parra-Cid T; Sanz-de-Villalobos E
    J Viral Hepat; 2013 Feb; 20(2):85-94. PubMed ID: 23301543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
    World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences.
    Golden-Mason L; Klarquist J; Wahed AS; Rosen HR
    J Immunol; 2008 Mar; 180(6):3637-41. PubMed ID: 18322167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
    Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
    Yao ZQ; King E; Prayther D; Yin D; Moorman J
    Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
    Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
    Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.
    Owusu Sekyere S; Suneetha PV; Kraft AR; Zhang S; Dietz J; Sarrazin C; Manns MP; Schlaphoff V; Cornberg M; Wedemeyer H
    J Hepatol; 2015 Jan; 62(1):31-40. PubMed ID: 25131771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Osuch S; Laskus T; Perlejewski K; Berak H; Bukowska-Ośko I; Pollak A; Zielenkiewicz M; Radkowski M; Caraballo Cortés K
    Front Immunol; 2022; 13():832206. PubMed ID: 35386708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
    Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
    J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.